Oncology Drug Discovery Products and Services
Eurofins Pharma Discovery Services has an extensive portfolio of both in vitro and in vivo services that can add value to your oncology program from Target ID to Candidate Selection. Our products and services enable clients to make timely, data-driven, decisions in their oncology drug discovery programs.

  • Profile kinase inhibitors using our industry gold-standard KinaseProfiler™ Service
  • Test for efficacy and identify genomic biomarkers with our OncoPanel™ Cell-Based Profiling Service
  • Research in vivo safety & efficacy with our xenograft or syngeneic models
  • Assess off-target liability with our portfolio of in vitro pharmacology services such as SafetyScreen44™
  • Evaluate the ADME PK & Toxicology properties of your compound
  • Leverage our broad custom service capabilities for your drug discovery research

New!   Oncology Webinar Replay     New!   View our AACR 2017 Posters

475+

Kinase and Epigenetic Targets

900+

In Vitro Safety Assays

40+

Years of Experience with In Vitro Safety

15+

Years Providing ADME-Tox Assays

20+

Years Providing Cell-Based Assays

30+

Years of Experience with In Vivo Models

Download Our Oncology Brochure (.pdf)     Subscribe to Our Newsletter    Talk to an Expert

Products and Services

Built upon the expertise of Eurofins Discovery Services , Cerep & Panlabs.

Kinase Targets
Epigenetic Targets
Cell-Based Profiling
In Vitro Safety
ADME-Tox
In Vivo Safety & Efficacy
Flex Lab™ Custom Services
Contact Us